Progressive Care Announces Appointment of Two New Board Members to the Company's Board of Directors
22 December 2021 - 11:12PM
InvestorsHub NewsWire
MIAMI, FL -- December 22, 2021 -- InvestorsHub NewsWire --
Progressive Care Inc. (OTCQB:
RXMD) (“Progressive Care” or the “Company”), a personalized
healthcare services and technology company, is pleased to announce
that the Company has appointed Birute Norkute and Joseph Ziegler to
join the Company’s Board of Directors.
Read more
“We are truly excited to include both Birute and Joseph to the
Company’s Board,” commented Alan Jay Weisberg, CEO of Progressive
Care. “We strongly believe that Joseph’s deep knowledge in
healthcare, finance, and accounting with strong regulatory
oversight and Birute’s operating, practical experience and in-depth
expertise in healthcare regulations and processes will help the
Company meet its corporate goals and drive shareholder value over
the short, intermediate, and long term.”
Mr. Ziegler is currently the Chief Financial Officer of DAS
Health, a private-equity owned provider of IT Services to
healthcare providers. Mr. Ziegler previously served as CFO for
Encompass Onsite, where he led a team through a period of rapid
growth driven by acquisitions and new customer onboarding while
improving the financial infrastructure of the business.
Prior to joining Encompass, he held multiple roles as a CFO in
the healthcare industry, including Private Equity backed specialty
pharmacy Biomatrix, successfully driving top-line growth from $60
million to $500 million during his tenure with the company. Prior
to serving as CFO of Biomatrix, Mr. Ziegler served as CFO of Novis
Pharmaceuticals, driving the company’s growth from $60 million to
$200 million during his tenure and led the company’s sales process
to strategic acquirer Cardinal Health. He graduated from Florida
Atlantic University with an MBA following a BS in finance.
Ms. Norkute has been a key part of Progressive Care and its/our
pharmacy operations team since 2008 and has been leading the
Company’s operations since 2013. She stands out as the driving
force behind a number of critical accomplishments. As the chief
architect of the operational model for ensuring medication
adherence, her work is reflected in the Company’s consistent 5-star
performance ratings in pharmacy dispensing and medication therapy
management.
Before ascending to her current role as COO, Birute controlled
budgetary compliance for PharmCoRx locations leading to
efficiencies that were often superior to those of automated
systems. She also has strong experience managing the Company’s IT
infrastructure to ensure current protocols are in place for HIPAA
compliance and technological efficiency.
For more information about Progressive Care, please visit the
company’s website.
Connect and stay in touch with us on social media:
Progressive Care Inc.
https://www.progressivecareus.com/
https://twitter.com/ProgressCareUS
PharmCoRx
https://www.pharmcorx.com/
https://twitter.com/PharmCoRx
ClearMetrX
https://www.clearmetrx.com/
https://www.facebook.com/clearmetrx/
About Progressive Care:
Progressive Care Inc. (OTCQB:
RXMD), through its subsidiaries, is a Florida health services
organization and provider of Third-Party Administration (TPA), data
management, COVID-19 related diagnostics and vaccinations, 340B
contracted pharmacy services, prescription pharmaceuticals,
compounded medications, provider of tele-pharmacy services, the
sale of anti-retroviral medications, medication therapy management
(MTM), the supply of prescription medications to long-term care
facilities, and health practice risk management.
Cautionary Disclosure Regarding Forward-Looking Statements
Forward-Looking Statements contained herein that are not based
upon current or historical fact are forward-looking in nature and
constitute forward-looking statements within the meaning of Section
27A of the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934. Such forward-looking statements reflect the
Company’s expectations about its future operating results,
performance, and opportunities that involve substantial risks and
uncertainties. When used herein, the words “anticipate,” “believe,”
“estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and
similar expressions, as they relate to Progressive Care Inc., its
subsidiaries, or its management, are intended to identify such
forward-looking statements. These forward-looking statements are
based on information currently available to the Company and are
subject to a number of risks, uncertainties, and other factors that
could cause the Company’s actual results, performance, prospects,
and opportunities to differ materially from those expressed in, or
implied by, these forward-looking statements.
Public Relations Contact:
Carlos Rangel
carlosr@pharmcorx.com
Progressive Care (QB) (USOTC:RXMD)
Historical Stock Chart
From Apr 2024 to May 2024
Progressive Care (QB) (USOTC:RXMD)
Historical Stock Chart
From May 2023 to May 2024